You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 274 No. 14, October 11, 1995 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pediatric HIV Disease, Zidovudine in Pregnancy, and Unblinding Heelstick Surveys

Reframing the Debate on Prenatal HIV Testing

Howard Minkoff, MD; Anne Willoughby, MD, MPH

JAMA. 1995;274(14):1165-1168.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

FEDERAL AND state legislatures have recently taken up the issue of identification of newborns exposed to the human immunodeficiency virus (HIV). Proposed legislation (eg, the Coburn/Waxman HIV testing amendment to the Ryan White CARE Act, the Ackerman Newborn HIV Notification Act [HR 1289], and NY A4413 and NY 52704) would include consideration of "unblinding" newborn heelstick surveys, which, until quite recently, were performed anonymously for surveillance purposes. These surveys, which relied on the detection of passively acquired maternal antibody to HIV, allowed health departments to track the course of the HIV epidemic among women of reproductive age. By unblinding these surveys, ie, ending the anonymity built into current protocols, health departments would identify exposed newborns, who could then be provided with appropriate therapeutic and prophylactic interventions. Since identification of exposed newborns relies on serological testing for passively acquired maternal antibody, such unblinding identifies infected women, and this discussion becomes, in . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Obstetrics and Gynecology, State University of New York Health Science Center at Brooklyn (Dr Minkoff), and the Pediatric, Adolescent, and Maternal AIDS Branch, Center for Research for Mothers and Children, National Institute of Child Health and Human Development, National Institutes of Health, Rockville, Md (Dr Willoughby).


Footnotes

This article does not represent the opinion of the US Public Health Service.

Reprint requests to Department of Obstetrics and Gynecology, SUNY Brooklyn Health Science Center, 450 Clarkson Ave, Box 24, Brooklyn, NY 11203 (Dr Minkoff).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.